HomeHealthcareHealthcare Services Medical Device Testing Market

Medical Device Testing Market Size, Share & Trends Analysis Report By Service Type (Testing Services, Inspection Services, Certification Services), By Testing Type (Physical Testing, Chemical & Biological Testing, Cybersecurity Testing, Microbiology & Sterility Testing), By Phase (Preclinical, Clinical), By Sourcing Type (In-House, Outsourced), By Technology (Active Implant Medical Device, Active Medical Device, Non-Active Medical Device, In-Vitro Diagnostic Medical Device, Others), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: November 05, 2026 | Author: Debashree Bora | Format:

Medical Device Testing Market Size & Growth Analysis

The global medical device testing market size was valued at USD 8.52 billion in 2025 and is projected to grow from USD 8.90 billion in 2026 to USD 12.66 billion by 2034, registering a CAGR of 4.5% during the forecast period from 2026 to 2034. North America dominated the medical device testing market with a market share of 38.4% in 2025.

Medical Device Testing refers to the evaluation of medical devices to verify their safety, performance, quality, and compliance with regulatory standards. It includes testing for biocompatibility, electrical safety, mechanical performance, sterility, durability, and functionality before devices are approved for use.

Medical Device Testing Market Key Takeaways

Global Market Size & Growth

Global Market Size (2025)
USD 8.52 billion
Global Market Size (2026)
USD 8.90 billion
Projected Market Size (2034)
USD 12.66 billion
Market CAGR (2026–2034)
4.5%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.4%
Fastest-growing Region
Asia-Pacific
Asia-Pacific CAGR (2026–2034)
7.84%

Segment Insights

By Service Type
Leading Segment
Testing Services
Market Share in 2025 61.5%
By Testing Type
Fastest-growing Segment
Cybersecurity testing
CAGR 8.43% (2026–2034)
By Phase
Leading Segment
Preclinical
Market Share in 2025 57.9%
By Sourcing Type
Fastest-growing Segment
Outsourced
CAGR 6.89% (2026–2034)
By Technology
Leading Segment
Non-Active Medical Device
Market Share in 2025 22.8%
Medical Device Testing Market Size , Share and Growth Forecast 2026-2034

Download a Free SampleTo learn more about this report.

Medical Device Testing Market Dynamics

01

Medical Device Innovation Market Drivers

Continuous innovation in medical devices increases the need for testing to verify product safety, accuracy, and performance before market entry. New technologies and complex device designs require detailed evaluation to identify technical issues and ensure reliable operation. For example, wearable glucose monitors and advanced diagnostic devices undergo performance and reliability testing before commercial use. This innovation increases demand for specialized testing services and advanced laboratory capabilities.

02

Growing Medical Device Manufacturing Boost Market Demand

Growing medical device manufacturing increases the volume of products that require quality checks and validation during production. Manufacturers depend on testing services to identify defects, verify material quality, and maintain consistent product performance across batches. For example, production facilities for surgical instruments and infusion pumps conduct mechanical, electrical, and functional tests before product release. Higher manufacturing output supports recurring demand for testing services and creates opportunities for testing laboratories.

03

Impact Analysis of Key Drivers in Medical Device Testing Market

Drivers

Market Impact

Rising Medical Device Innovation

Increasing development of advanced diagnostic, monitoring, and therapeutic devices creates demand for performance, safety, and reliability testing before commercialization.

Growing Medical Device Manufacturing

Higher production volumes increase the need for routine quality inspections, material testing, and batch validation, supporting demand for specialized testing services.

Increasing Use of Implantable Devices

Wider use of orthopedic implants, cardiac devices, and other implantable products raises demand for biocompatibility, durability, and mechanical performance testing.

Expansion of Home Healthcare Devices

Growing use of portable diagnostic and monitoring equipment increases the need for electrical safety, functional performance, and reliability testing across device categories.

Rising Medical Device Recalls

Product failures and safety incidents encourage manufacturers to strengthen testing and quality assurance processes, increasing demand for independent testing and validation services.

01

High Cost of Testing and Certification

High costs of testing and certification increase the financial burden on medical device manufacturers, particularly smaller companies with limited compliance budgets. Specialized testing equipment, repeated evaluations, and certification fees add to product development expenses. These costs can discourage manufacturers from using extensive testing services and slow the adoption of new medical devices.

02

Complex and Changing Regulatory Requirements

Complex and changing regulatory requirements create challenges for manufacturers seeking approval across different markets. Variations in safety standards, documentation rules, and testing protocols require additional evaluations and compliance efforts. These requirements can extend approval timelines, delay product launches, and restrict the growth of medical device testing services.

03

Impact Analysis of Key Restraints in Medical Device Testing Market

Restraints

Market Impact

High Cost of Testing and Certification

Extensive testing procedures, specialized equipment, and certification expenses increase product development costs, making compliance difficult for smaller medical device manufacturers.

Complex and Changing Regulatory Requirements

Differences in regulatory standards across countries and frequent compliance updates increase testing complexity, extend approval timelines, and delay product commercialization.

Shortage of Skilled Testing Professionals

Limited availability of specialists in biocompatibility, electrical safety, clinical evaluation, and regulatory compliance can restrict laboratory capacity and delay testing activities.

Limited Availability of Advanced Testing Infrastructure

High investment requirements for specialized laboratories and advanced testing equipment can restrict service availability, particularly in emerging markets.

Long Testing and Validation Timelines

Extensive performance, safety, and reliability evaluations can extend product development cycles, delay market entry, and increase costs for medical device manufacturers.

01

Outsourced Testing and Regulatory Consulting

Medical device manufacturers, startups, and small healthcare technology companies can benefit from outsourced testing and regulatory consulting to manage compliance costs and access specialized expertise. Testing laboratories and consulting firms can generate revenue through product validation, regulatory documentation, certification support, and long-term testing contracts, with companies such as Eurofins Scientific and TÜV SÜD offering relevant services.

02

Specialized Biocompatibility Testing Services

Medical device manufacturers, implant developers, and material suppliers create demand for specialized biocompatibility testing to assess the safety of materials used in medical applications. Testing service providers can expand revenue through cytotoxicity, irritation, sensitization, and other biological evaluation services, with companies such as Nelson Labs and Charles River Laboratories offering relevant testing capabilities.

Medical Device Testing Market Segmental Analysis

By Service Type

Testing services accounted for the largest share of the medical device testing market at 61.5%, driven by stringent regulatory requirements, increasing demand for product safety and performance validation, and the growing complexity of medical devices.

Testing services are also projected to record the highest CAGR of 6.52%, supported by rising medical device innovation, expanding regulatory compliance requirements, and the need for comprehensive testing throughout product development and commercialization.

Medical Device Testing Market Size By Segments

Request Customizationto receive a tailored report.

By Testing Type

Physical testing held the largest market share at 34.6%, supported by the need to assess device durability, mechanical performance, reliability, and compliance with safety standards before market approval.

Cybersecurity testing is expected to grow at the highest CAGR of 8.43%, driven by increasing connectivity in medical devices, rising cyber threats, and stricter requirements for protecting patient data and connected healthcare systems.

By Phase

The preclinical segment is projected to grow at a CAGR of 6.18%, driven by the need to evaluate device safety, functionality, and performance before clinical evaluation and regulatory submission.

The clinical segment is expected to register a CAGR of 6.34%, supported by increasing clinical investigations, growing development of innovative medical technologies, and the need to demonstrate device safety and effectiveness in human use.

By Sourcing Type

The in-house segment is projected to grow at a CAGR of 5.41%, supported by manufacturers’ preference for greater control over testing procedures, confidential product information, and internal quality management.

The outsourced segment is expected to record a CAGR of 6.89%, driven by increasing demand for specialized testing expertise, cost efficiency, access to advanced laboratory infrastructure, and support in meeting complex regulatory requirements.

By Technology

The non-active medical device segment accounted for the largest market share at 22.8%, driven by the extensive use of instruments and devices that do not require an external power source, alongside stringent requirements for safety, material quality, and performance validation.

In-vitro diagnostic medical devices are projected to register the highest CAGR of 7.16%, supported by growing demand for advanced diagnostic technologies, increasing adoption of rapid and molecular testing, and the need for accurate and reliable diagnostic results.

Medical Device Testing Market Share By Segments

Speak to an Analystto discuss market opportunities.

Medical Device Testing Market Regional Analysis 

North America Medical Device Testing Market

The North America medical device testing market accounted for the largest regional share of 38.4% in 2025.

U.S. Medical Device Testing Market

The U.S. medical device testing market could benefit from stronger quality and compliance requirements, as the FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, incorporates ISO 13485:2016 into its regulatory framework, increasing the importance of quality-system assessments, product verification, and compliance testing; additionally, the FDA issued updated medical-device cybersecurity guidance in February 2026, reinforcing testing needs for connected devices.

Canada Medical Device Testing Market

Canada’s medical device testing market could benefit from evolving regulatory and product-safety requirements, as Health Canada’s amended medical-device shortage and discontinuation reporting rules are scheduled to take effect on June 17, 2027, while its updated framework for medical device establishment licences takes effect on December 14, 2026, strengthening supplier transparency and compliance oversight and supporting demand for testing and quality-assurance services.

North America Medical Device Testing Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Medical Device Testing Market

The Asia Pacific medical device testing market is expected to grow at a CAGR of 7.84% during the forecast period 2026–2034, showcasing the fastest-growing regional market.

Japan Medical Device Testing Market

Japan’s medical device testing market could benefit from the government’s push to accelerate medical-device innovation and international market access, with METI’s Medical Device Industry Vision 2024 prioritising AI-enabled devices, clinical evidence development, and global regulatory readiness, which may increase demand for product validation and compliance testing.

China Medical Device Testing Market

China’s medical device testing market could benefit from stronger regulatory oversight, as the State Council targets a more comprehensive medical-device regulatory system by 2027 and modernised regulation by 2035, with plans to strengthen lifecycle supervision, improve national standards, and establish standardisation bodies for emerging technologies such as AI and medical robots.

India Medical Device Testing Market

India’s medical device testing market could benefit from dedicated testing infrastructure, as the government’s ₹300 crore Medical Device Parks Scheme provides central assistance of up to ₹100 crore per park for common testing, sterilisation, and prototyping facilities, while the ₹500 crore Scheme for Strengthening of Medical Device Industry runs through FY2027–28 to support testing and manufacturing capabilities.

Europe Medical Device Testing Market

The Europe medical device testing market accounted for the regional share of 27.6% in 2025.

U.K. Medical Device Testing Market

The U.K. medical device testing market could benefit from regulatory modernisation, as the government aims to make the country one of Europe’s top three fastest destinations for patient access to medicines and medical technologies by 2030, while the MHRA plans to strengthen lifecycle safety monitoring, device traceability, and regulatory oversight of AI-enabled medical devices, supporting demand for product verification and compliance testing.

Germany Medical Device Testing Market

Germany’s medical device testing market could benefit from expanding diagnostic-device demand, as the country’s in-vitro diagnostics (IVD) market is projected to exceed €10.06 billion by 2030, compared with approximately €7 billion in 2024, while its broader medical technology market is expected to grow at a 3.3% CAGR through 2029, supporting demand for device performance, safety, and regulatory-compliance testing.

Competitive landscape

The medical device testing market is moderately fragmented, with participation from established testing, inspection, and certification companies, specialized medical device testing laboratories, contract research organizations, regulatory consulting firms, and independent testing providers. The leading players in the medical device testing market are SGS, Eurofins Scientific, Bureau Veritas, Intertek, and Element Materials Technology, with these five companies estimated to collectively account for approximately 45–50% of the global medical device testing market share; this is an indicative estimate, as the exact combined share is not publicly disclosed.

Established players primarily compete on testing accuracy, regulatory expertise, laboratory accreditation, service portfolio, technical capabilities, global laboratory networks, turnaround time, and relationships with medical device manufacturers. Emerging players generally compete through advanced testing technologies, specialized testing services, faster turnaround times, cost-effective solutions, flexible service models, digital testing processes, and expertise in areas such as biocompatibility, software validation, cybersecurity, and connected medical devices within the medical device testing market ecosystem.

List of Key and Emerging Players in Medical Device Testing Market

SGS SA (Switzerland)
Eurofins Scientific SE (Luxembourg)
Bureau Veritas SA (France)
Intertek Group plc (United Kingdom)
Element Materials Technology (United Kingdom)
Envigo (United Kingdom)
Avomeen Analytical Services (U.S.)
Gateway Analytical, LLC (U.S.)
Medistri SA (Switzerland)
North American Science Associates, LLC (U.S.)
Pace Analytical Services, LLC (U.S.)

Key Industry Developments

April 2026
Eurofins Scientific expanded its medical device testing capabilities by upgrading laboratory infrastructure and adding advanced testing services for connected medical devices, implants, and combination products. The expansion strengthens Eurofins’ support for manufacturers requiring regulatory compliance, safety testing, and performance validation.
February 2026
UL Solutions expanded its healthcare and medical device testing portfolio by introducing enhanced cybersecurity and safety testing services for connected medical devices. The new capabilities support manufacturers developing IoT-enabled medical equipment requiring compliance with evolving safety and digital security requirements.
October 2025
TÜV SÜD expanded its medical device testing and certification capabilities by opening upgraded laboratory facilities focused on active medical devices, software-based medical technologies, and digital health products. The expansion improves testing capacity for manufacturers seeking global regulatory approvals.
June 2025
Intertek Group plc expanded its medical device assurance services by adding advanced biocompatibility, electrical safety, and performance testing capabilities at its healthcare testing laboratories. The expansion supports medical device manufacturers throughout product development and regulatory submission processes.

Report Scope

Segmentation

By Service Type 3
  • Testing Services
  • Inspection Services
  • Certification Services
By Testing Type 4
  • Physical testing
  • Chemical and biological testing
  • Cybersecurity testing
  • Microbiology and sterility testing
By Phase 2
  • Preclinical
  • Clinical
By Sourcing Type 2
  • In-house
  • Outsourced
By Technology 7
  • Active Implant Medical Device
  • Active Medical Device
  • Non-Active Medical Device
  • In-vitro Diagnostic Medical Device
  • Ophthalmic Medical Device
  • Orthopedic and Dental Medical Devices
  • Vascular Medical Device

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage SGS SA (Switzerland) · Eurofins Scientific SE (Luxembourg) · Bureau Veritas SA (France) · Intertek Group plc (United Kingdom) · Element Materials Technology (United Kingdom)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Reportto Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The medical device testing market size is valued at USD 8.90 Billion in 2026 and is projected to reach USD 12.66 Billion by 2034, at a CAGR of 4.5% during the forecast period 2026-2034.
North America dominated the market with a share of 38.4% in 2025.
The leading players in this market are SGS, Eurofins Scientific, Bureau Veritas, Intertek, Elements Material Technology.
The medical device testing market is projected to grow at a CAGR of 4.5% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG ElectronicsAMCAD EngineeringKOBE STEEL LTD.Hindustan National Glass & Industries LimitedVoith GroupInternational PaperHansol PaperWhirlpool CorporationSonySamsung ElectronicsQualcommGoogleFiservVeto-PharmaNippon Becton DickinsonMerckArgon Medical DevicesAbbottAjinomotoDenonDoosanMeiji Seika Kaisha LtdLG ChemicalsLCY chemical groupBayerAirraneBASFToyota IndustriesNissan MotorsNeenahMitsubishiHyundai Motor CompanyHondaCRP Industries IncpewagLGEPanasonicLubrizol CorporationLeonardoJohnson & JohnsonHB FullerMITSUBISHI CHEMICALHyundai MobisAmazon
Request SampleOrder Report Now